Cannabist Company Holdings (FRA:VW5) Notes Receivable: €0.4 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VW5 Cannabist Company Holdings Inc FRA:VW5
34 GF Score
Price €0.02
GF Value €15.00
! 3 Warning Signs
View Full Analysis

What is Cannabist Company Holdings Notes Receivable?

Cannabist Company Holdings FRA:VW5 34 Notes Receivable is €0.4 Mil as of Sep. 2025. GuruFocus rates FRA:VW5 with a GF Score™ of 34/100 and a GF Value™ of €15.00. The stock has 3 warning signs investors should review.

Cannabist Company Holdings's Notes Receivable for the quarter that ended in Sep. 2025 was €0.4 Mil.

Cannabist Company Holdings's quarterly Notes Receivable declined from Mar. 2025 (€13.91 Mil) to Jun. 2025 (€0.50 Mil) but then stayed the same from Jun. 2025 (€0.50 Mil) to Sep. 2025 (€0.43 Mil).

Cannabist Company Holdings's annual Notes Receivable increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€3.69 Mil) and increased from Dec. 2023 (€3.69 Mil) to Dec. 2024 (€14.91 Mil).

Cannabist Company Holdings Notes Receivable Related Terms

Cannabist Company Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for Cannabist Company Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabist Company Holdings Notes Receivable Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 3.69 14.91

Cannabist Company Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.45 14.91 13.91 0.50 0.43
FRA:VW5
34GF Score
Cannabist Company Holdings Inc FRA:VW5
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannabist Company Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.4 Mil mean?
Cannabist Company Holdings (FRA:VW5) has a Notes Receivable of €0.4 Mil as of Sep. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Cannabist Company Holdings and its competitors.
Is Cannabist Company Holdings' Notes Receivable too high?
Cannabist Company Holdings' current Notes Receivable is €0.4 Mil. Overall, Cannabist Company Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cannabist Company Holdings' Notes Receivable compare to OWPC and AYURF?
Cannabist Company Holdings' Notes Receivable of €0.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Cannabist Company Holdings and its competitors. Cannabist Company Holdings's current Notes Receivable is €0.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Cannabist Company Holdings (FRA:VW5) has a current Notes Receivable of €0.4 Mil. The stock's GF Value™ is €15.00, compared to a current price of €0.02 — trading 99.9% below its estimated fair value. The current Notes Receivable is €0.4 Mil. Cannabist Company Holdings' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Cannabist Company Holdings (FRA:VW5), the current Notes Receivable is €0.4 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannabist Company Holdings (FRA:VW5) Overvalued in 2026?

Based on GuruFocus' analysis, Cannabist Company Holdings stock appears to be undervalued. The current stock price of €0.02 is trading 99.9% below its estimated GF Value™ of €15.00.

Key valuation signals for FRA:VW5:

  • Notes Receivable: €0.4 Mil
  • GF Value™: €15.00 vs. price of €0.02 (99.9% below fair value)
  • GF Score™: 34/100 with 3 warning signs

No single metric tells the full story. See the FRA:VW5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannabist Company Holdings Business Description

Other Exchanges CBSTQ:USA
Address 321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
34GF Score

Get the complete analysis for FRA:VW5

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€15.00
GF Value